CELATOR PHARMACEUTICALS

Celator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1 (Irinotecan HCI-Floxuridine), a treatment for colorectal cancer; and CPX-351 (Cytarabine-Daunorubicin), a treatment for acute myeloid leukemia (AML). Celator Pharmaceuticals, Inc. was formerly known as Celator Technologies, Inc. The company was founded in 2000 and is headquartered in Princeton, New Jersey.
CELATOR PHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Health Care Health Diagnostics Medical Pharmaceutical
Founded:
1999-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.celatorpharma.com
Total Employee:
11+
Status:
Active
Contact:
(609) 243-0123
Email Addresses:
[email protected]
Total Funding:
131.88 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Wix Hosted Proofpoint CSC Global DNS
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical companyย focused on theย prevention and treatment of gastrointestinal disorders.
Sorrento Therapeutics
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Hercules Capital
Hercules Capital investment in Debt Financing - Celator Pharmaceuticals
ROTH Capital Partners
ROTH Capital Partners investment in Private Equity Round - Celator Pharmaceuticals
Valence Life Sciences
Valence Life Sciences investment in Private Equity Round - Celator Pharmaceuticals
Ventures West
Ventures West investment in Series D - Celator Pharmaceuticals
TL Ventures
TL Ventures investment in Series D - Celator Pharmaceuticals
Quaker BioVentures
Quaker BioVentures investment in Series D - Celator Pharmaceuticals
Domain Associates
Domain Associates investment in Series D - Celator Pharmaceuticals
GrowthWorks Capital
GrowthWorks Capital investment in Series D - Celator Pharmaceuticals
BDC Venture Capital
BDC Venture Capital investment in Series D - Celator Pharmaceuticals
Thomas, McNerney & Partners
Thomas, McNerney & Partners investment in Series D - Celator Pharmaceuticals
Official Site Inspections
http://www.celatorpharma.com
- Host name: 165.160.13.20
- IP address: 165.160.13.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Celator Pharmaceuticals"
Celator Pharmaceuticals 2025 Company Profile: โฆ
Information on acquisition, funding, cap tables, investors, and executives for Celator Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Celator Pharmaceuticals - Crunchbase Company Profile โฆ
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.See details»
Celator Pharmaceuticals Corp., Vancouver, British Columbia
Celator Technologies is a private North American biopharmaceutical company developing new carrier technology for targeting combinations of rationally selected chemotherapeutic agents to โฆSee details»
Celator Pharmaceuticals Inc. | BDC.ca
Celator is a biopharmaceutical company working to develop new and more effective therapies to treat cancer. CombiPlex, the company's drug ratio technology platform, represents a revolutionary new approach to the โฆSee details»
Celator Pharmaceuticals - Capital Compass BC
Celator Pharmaceuticals, operator of a pharmaceutical company intended to improve clinical outcomes. Here you'll find information about their funding, investors and team.See details»
Celator Pharmaceuticals Management Team | Org Chart
Celator Pharmaceuticals employs 14 employees. The Celator Pharmaceuticals management team includes Arthur Louie (Chief Medical Officer), Donna Caputo Alvarez (Manager, Clinical โฆSee details»
Celator Pharmaceuticals Corp - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Celator Pharmaceuticals Corp of Vancouver, BC. Get the latest business insights from Dun & Bradstreet.See details»
Celator Pharmaceuticals - Ownership and Business Overview - Mergr
Celator Pharmaceuticals, Inc. is an oncology-focused biopharmaceutical company that is transforming the science of combination therapy, and developing products to improve patient โฆSee details»
Celator Pharmaceuticals - VentureRadar
Celator Pharmaceuticals, Inc., with locations in Princeton, NJ, and Vancouver, BC, is a privately held pharmaceutical company developing new and more effective therapies to treat cancer. โฆSee details»
Celator Pharmaceuticals Company Overview, Contact Details
Celator Pharmaceuticals 's official website is celatorpharma.com and has social profiles on LinkedIn. What is Celator Pharmaceuticals's SIC code NAICS code? Celator Pharmaceuticals โฆSee details»
Celator Pharmaceuticals, Inc. - CMOCRO
Celator Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company that is transforming the science of combination therapy, and developing products to improve patient outcomes in โฆSee details»
Celator Pharmaceuticals Overview | SignalHire Company Profile
Celator Pharmaceuticals is a private company that has been in the industry for 24 years. The company currently specializes in the Biotechnology area. The position of the CEO is occupied โฆSee details»
Celator Pharmaceuticals Information - RocketReach
Celator Pharmaceuticals is a Biotechnology, Drug Stores & Pharmacies, and Biopharma company_reader located in Ewing, New Jersey with $100 million in revenue and 14 โฆSee details»
CELATOR PHARMACEUTICALS CORP Company Insights, Tech โฆ
Find useful insights on Celator Pharmaceuticals's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Celator โฆSee details»
Celator Pharmaceuticals, Vancouver, CA | Company Information
Amend the information Add my company Search for a company anywhere in the world Celator Pharmaceuticals No ratings 1779 75th Ave W V6P 6P2 Vancouver British Columbia - Canada โฆSee details»
Celator Pharmaceuticals, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Celator Pharmaceuticals, Inc. of Ewing, NJ. Get the latest business insights from Dun & Bradstreet.See details»
Celator (CPXX): A Unique Drug Ratio Technology Company for โฆ
May 28, 2014 Over the years, Celator has developed a unique, proprietary drug combination platform technology: CombiPlex. Combination therapy is a powerful and effective therapeutic โฆSee details»
Celator Pharmaceuticals - Profiles & Contacts - Crunchbase
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.See details»
Celator Pharmaceuticals Corp · 887 Great Northern Way, Unit 250 ...
Celator Pharmaceuticals Corp is a business in Vancouver licensed by the Business Licence Office of the Development, Buildings, and Licensing Division of the City of Vancouver. The licence โฆSee details»
Congratulations to BC Cancer Agency spin-out success, Celator ...
Jun 2, 2016 Farris Partner Hector MacKay-Dunn, Q.C. extends the Firmโs congratulations to Celator Pharmaceuticals, Ewing, N.J./Vancouver, B.C. and Jazz Pharmaceuticals, Dublin on โฆSee details»